Amgen Group

Total cases

Claimant-side

Respondent-side

Amgen Group has been party to 25 Unified Patent Court cases, 11 times as claimant and 14 times as respondent. The most recent on record is UPC CFI 2220/2025 at the Munich Central Division.

Group members

9 entities · 25 cases combined

Adversary analytics require an account

Recent cases

Latest filings involving this group and its entities.

View all cases

2025-12-23UPC CFI 2220/2025Munich CD—Amgen Inc. v Sanofi-Aventis Deutschland GmbH
2025-12-23UPC CFI 2221/2025Munich CD—Amgen Inc. v Regeneron Pharmaceuticals Inc.
2025-07-14UPC CoA 641/2025Court of AppealWithdrawnSanofi Biotechnology SAS v Amgen Inc.
2025-07-11UPC CoA 646/2025Court of AppealWithdrawnAmgen NV v Regeneron Pharmaceuticals Inc.
2025-06-16UPC CFI 534/2025Dusseldorf LD—Amgen S.A.S. v Sanofi Biotechnology SAS
2025-02-28UPC CFI 195/2025Dusseldorf LDWithdrawnSanofi Biotechnology SAS v Amgen Inc.
2025-01-21UPC APP 3053/2025Hamburg LD—Amgen GmbH v Alexion Pharmaceuticals, Inc.
2025-01-21UPC APP 3214/2025Munich CD—Name not displayed for GDPR reasons. Represented by Sture RYGAARD v Sanofi-Aventis Deutschland GmbH
2024-10-31UPC CFI 642/2024Milan CDWithdrawnAMGEN Switzerland AG Vilniaus filialas v Alexion Pharmaceuticals, Inc.
2024-09-13UPC CoA 528/2024Court of AppealPatent upheld as grantedAmgen Inc. v Sanofi-Aventis Deutschland GmbH